Monopar Therapeutics (MNPR) Gains from Investment Securities (2018 - 2025)

Quarterly results put Gains from Investment Securities at -$127342.0 for Q4 2025, down 290.22% from a year ago — trailing twelve months through Dec 2025 was -$55074.0 (down 161.81% YoY), and the annual figure for FY2025 was $616555.0, up 43.75%.

Monopar Therapeutics has reported Gains from Investment Securities over the past 8 years, most recently at -$127342.0 for Q4 2025.

  • Gains from Investment Securities reached -$127342.0 in Q4 2025 per MNPR's latest filing, down from $248381.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.6 million in Q3 2022 and bottomed at -$127342.0 in Q4 2025.
  • Median Gains from Investment Securities over the past 5 years was $66946.0 (2024), compared with a mean of $266745.3.
  • The largest annual shift saw Gains from Investment Securities skyrocketed 1157.91% in 2024 before it crashed 290.22% in 2025.
  • Over 5 years, Gains from Investment Securities stood at $115151.0 in 2021, then tumbled by 113.66% to -$15726.0 in 2022, then surged by 133.84% to $5322.0 in 2023, then surged by 1157.91% to $66946.0 in 2024, then plummeted by 290.22% to -$127342.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for MNPR at -$127342.0 in Q4 2025, $248381.0 in Q3 2025, and $23527.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Monopar Therapeutics 466.82 Mn 466.82 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -127,342.00
Dec 31, 2025 -127,342.00
Sep 30, 2025 248,381.00
Sep 30, 2025 248,381.00
Jun 30, 2025 23,527.00
Jun 30, 2025 23,527.00
Mar 31, 2025 216,331.00
Mar 31, 2025 216,331.00
Dec 31, 2024 66,946.00
Dec 31, 2024 66,946.00
Sep 30, 2024 43,523.00
Sep 30, 2024 43,523.00
Jun 30, 2024 78,592.00
Jun 30, 2024 78,592.00
Dec 31, 2023 5,322.00
Dec 31, 2023 5,322.00
Sep 30, 2023 42,851.00
Sep 30, 2023 42,851.00
Mar 31, 2023 16,827.00
Mar 31, 2023 16,827.00
Dec 31, 2022 -15,726.00
Dec 31, 2022 -15,726.00
Sep 30, 2022 1.62 Mn
Sep 30, 2022 1.62 Mn
Jun 30, 2022 205,933.00
Jun 30, 2022 205,933.00
Mar 31, 2022 53,694.00
Mar 31, 2022 53,694.00
Dec 31, 2021 115,151.00
Dec 31, 2021 115,151.00
Sep 30, 2021 400,476.00
Sep 30, 2021 400,476.00
Jun 30, 2021 1.54 Mn
Jun 30, 2021 1.54 Mn
Dec 31, 2020 1.26 Mn
Dec 31, 2020 1.26 Mn
Dec 31, 2019 1.09 Mn
Dec 31, 2019 1.09 Mn
Dec 31, 2018 -65,731.00
Dec 31, 2018 -65,731.00